---
title: "YAROSHEVSKY GLANVILLE MARY — Ownership Dossier"
canonical: https://whiteintel.dev/entity/641e38c0-d136-59dc-bdb1-ab9bbd16e6ab
json: https://whiteintel.dev/api/public/dossier/641e38c0-d136-59dc-bdb1-ab9bbd16e6ab
identifier: sec:0001283305
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# YAROSHEVSKY GLANVILLE MARY

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001283305`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/641e38c0-d136-59dc-bdb1-ab9bbd16e6ab  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/641e38c0-d136-59dc-bdb1-ab9bbd16e6ab  

## Ownership & control

### Holdings / subsidiaries

- **ANADYS PHARMACEUTICALS INC** (officer) — https://whiteintel.dev/entity/5dfaf710-d4e2-52dc-8fc5-3a6963b28b0d

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **YAROSHEVSKY GLANVILLE MARY**. Human view: https://whiteintel.dev/entity/641e38c0-d136-59dc-bdb1-ab9bbd16e6ab · Structured JSON: https://whiteintel.dev/api/public/dossier/641e38c0-d136-59dc-bdb1-ab9bbd16e6ab._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._